Management of Breast Mass with Previous Benign Excision Biopsy
Assessment of the Current Situation
- For a patient with a history of excision biopsy showing benign findings, routine breast screening is the recommended approach rather than additional surgery, as per the National Comprehensive Cancer Network 2, 3
- When a previous excision biopsy has confirmed benign pathology that is concordant with imaging, the patient should return to routine screening protocols, according to the National Comprehensive Cancer Network 1, 4
- The upper outer quadrant location does not change management when previous pathology was benign, as stated by the American Cancer Society 5
Follow-up Recommendations After Benign Biopsy
- Physical examination with or without ultrasound or mammogram is recommended every 6-12 months for 1-2 years to ensure stability of the biopsy site, as recommended by the National Comprehensive Cancer Network 1, 3
- After 1-2 years of stability, the patient can return to routine breast screening, as suggested by the National Comprehensive Cancer Network 3
When Additional Intervention Would Be Warranted
- If the previously biopsied area shows an increase in size during follow-up, repeat tissue sampling should be performed, as recommended by the National Comprehensive Cancer Network 1, 3
- New suspicious features on imaging (BI-RADS 4 or 5) would warrant additional biopsy rather than immediate surgical excision, according to the American College of Radiology 7, 4
- If there is discordance between pathology and imaging findings from the previous biopsy, surgical excision would be indicated, as stated by the National Comprehensive Cancer Network 2, 4
Specific Scenarios Requiring Further Intervention
- Atypical findings on previous pathology (atypical hyperplasia, LCIS) would require consideration of risk reduction therapy rather than additional surgery, as recommended by the National Comprehensive Cancer Network 1, 3
- Papillary lesions, radial scars, or potential phyllodes tumors on previous pathology may warrant surgical excision even with benign findings, according to the National Comprehensive Cancer Network 2, 3